Structure and Aggregation Mechanisms in Amyloids
Main Author: | |
---|---|
Publication Date: | 2020 |
Other Authors: | |
Format: | Article |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | https://hdl.handle.net/10316/106460 https://doi.org/10.3390/molecules25051195 |
Summary: | The aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's and Huntington's diseases are some of the approximately 50 amyloid diseases described to date. The identification and characterization of the molecular species critical for amyloid formation and disease development have been the focus of intense scrutiny. Methods such as X-ray and electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) and cryo-electron microscopy (cryo-EM) have been extensively used and they have contributed to shed a new light onto the structure of amyloid, revealing a multiplicity of polymorphic structures that generally fit the cross-β amyloid motif. The development of rational therapeutic approaches against these debilitating and increasingly frequent misfolding diseases requires a thorough understanding of the molecular mechanisms underlying the amyloid cascade. Here, we review the current knowledge on amyloid fibril formation for several proteins and peptides from a kinetic and thermodynamic point of view, the structure of the molecular species involved in the amyloidogenic process, and the origin of their cytotoxicity. |
id |
RCAP_edcb98594642b7256bc3e7c99b97cc05 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/106460 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Structure and Aggregation Mechanisms in Amyloidsmisfolding diseasesamyloidosisoligomersaggregatesaggregationaggregation mechanismssteric zipperamyloid fibrilsamyloid structureamyloid dyesAmino Acid MotifsAmino Acid SequenceAmyloidAmyloid beta-PeptidesAnimalsComputational BiologyHumansKineticsMolecular StructureProtein BindingStructure-Activity RelationshipThermodynamicsModels, MolecularProtein AggregatesProtein Aggregation, PathologicalProtein ConformationThe aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's and Huntington's diseases are some of the approximately 50 amyloid diseases described to date. The identification and characterization of the molecular species critical for amyloid formation and disease development have been the focus of intense scrutiny. Methods such as X-ray and electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) and cryo-electron microscopy (cryo-EM) have been extensively used and they have contributed to shed a new light onto the structure of amyloid, revealing a multiplicity of polymorphic structures that generally fit the cross-β amyloid motif. The development of rational therapeutic approaches against these debilitating and increasingly frequent misfolding diseases requires a thorough understanding of the molecular mechanisms underlying the amyloid cascade. Here, we review the current knowledge on amyloid fibril formation for several proteins and peptides from a kinetic and thermodynamic point of view, the structure of the molecular species involved in the amyloidogenic process, and the origin of their cytotoxicity.The authors acknowledge funding from the Fundação para a Ciência e a Tecnologia (FCT), Portuguese Agency for Scientific Research, through project UID/QUI/00313/2019 (to Coimbra Chemistry Centre, University of Coimbra) and programs COMPETE and CENTRO-2020. Z.L.A. also thanks FCT for doctoral fellowship SFRH/BD/137991/2018.MDPI2020-03-06info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://hdl.handle.net/10316/106460https://hdl.handle.net/10316/106460https://doi.org/10.3390/molecules25051195eng1420-3049Almeida, Zaida L.Brito, Rui M. M.info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-19T17:25:27Zoai:estudogeral.uc.pt:10316/106460Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T05:57:12.563359Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Structure and Aggregation Mechanisms in Amyloids |
title |
Structure and Aggregation Mechanisms in Amyloids |
spellingShingle |
Structure and Aggregation Mechanisms in Amyloids Almeida, Zaida L. misfolding diseases amyloidosis oligomers aggregates aggregation aggregation mechanisms steric zipper amyloid fibrils amyloid structure amyloid dyes Amino Acid Motifs Amino Acid Sequence Amyloid Amyloid beta-Peptides Animals Computational Biology Humans Kinetics Molecular Structure Protein Binding Structure-Activity Relationship Thermodynamics Models, Molecular Protein Aggregates Protein Aggregation, Pathological Protein Conformation |
title_short |
Structure and Aggregation Mechanisms in Amyloids |
title_full |
Structure and Aggregation Mechanisms in Amyloids |
title_fullStr |
Structure and Aggregation Mechanisms in Amyloids |
title_full_unstemmed |
Structure and Aggregation Mechanisms in Amyloids |
title_sort |
Structure and Aggregation Mechanisms in Amyloids |
author |
Almeida, Zaida L. |
author_facet |
Almeida, Zaida L. Brito, Rui M. M. |
author_role |
author |
author2 |
Brito, Rui M. M. |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Almeida, Zaida L. Brito, Rui M. M. |
dc.subject.por.fl_str_mv |
misfolding diseases amyloidosis oligomers aggregates aggregation aggregation mechanisms steric zipper amyloid fibrils amyloid structure amyloid dyes Amino Acid Motifs Amino Acid Sequence Amyloid Amyloid beta-Peptides Animals Computational Biology Humans Kinetics Molecular Structure Protein Binding Structure-Activity Relationship Thermodynamics Models, Molecular Protein Aggregates Protein Aggregation, Pathological Protein Conformation |
topic |
misfolding diseases amyloidosis oligomers aggregates aggregation aggregation mechanisms steric zipper amyloid fibrils amyloid structure amyloid dyes Amino Acid Motifs Amino Acid Sequence Amyloid Amyloid beta-Peptides Animals Computational Biology Humans Kinetics Molecular Structure Protein Binding Structure-Activity Relationship Thermodynamics Models, Molecular Protein Aggregates Protein Aggregation, Pathological Protein Conformation |
description |
The aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's and Huntington's diseases are some of the approximately 50 amyloid diseases described to date. The identification and characterization of the molecular species critical for amyloid formation and disease development have been the focus of intense scrutiny. Methods such as X-ray and electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) and cryo-electron microscopy (cryo-EM) have been extensively used and they have contributed to shed a new light onto the structure of amyloid, revealing a multiplicity of polymorphic structures that generally fit the cross-β amyloid motif. The development of rational therapeutic approaches against these debilitating and increasingly frequent misfolding diseases requires a thorough understanding of the molecular mechanisms underlying the amyloid cascade. Here, we review the current knowledge on amyloid fibril formation for several proteins and peptides from a kinetic and thermodynamic point of view, the structure of the molecular species involved in the amyloidogenic process, and the origin of their cytotoxicity. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-03-06 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10316/106460 https://hdl.handle.net/10316/106460 https://doi.org/10.3390/molecules25051195 |
url |
https://hdl.handle.net/10316/106460 https://doi.org/10.3390/molecules25051195 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1420-3049 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833602528224215040 |